Scholar Rock's Series C Round

Scholar Rock raised a round of funding on January 03, 2018.

Scholar Rock (NASDAQ: SRRK) is discovering and developing a new class of biologic therapies to selectively target dysregulated growth factors in the disease microenvironment by modulating supracellula…

Articles about Scholar Rock's Series C Round: